III. Xenon - Cardiovascularly inert?

British Journal of Anaesthesia

Volumn 92, Issue 6, 2004, Pages 786-789

  Preckel, B ^a   Schlack, W ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INERT GAS; INHALATION ANESTHETIC AGENT; ISOFLURANE; NEUROPROTECTIVE AGENT; NITROUS OXIDE; PROPOFOL; REMIFENTANIL; XENON;

ANESTHETIC RECOVERY; BRAIN BLOOD FLOW; CLINICAL TRIAL; DRUG COST; DRUG MECHANISM; DRUG SAFETY; EDITORIAL; EISENMENGER COMPLEX; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INOTROPISM; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEUROPROTECTION; NONHUMAN; OXYGEN CONSUMPTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; ANIMAL; BLOOD FLOW; DRUG EFFECT; HEART; HEART DISEASE; HEMODYNAMICS; NOTE; ORGAN CULTURE TECHNIQUE; PATHOPHYSIOLOGY;

ANESTHETICS, INHALATION; ANIMALS; HEART; HEART DISEASES; HEMODYNAMIC PROCESSES; HUMANS; ORGAN CULTURE TECHNIQUES; REGIONAL BLOOD FLOW; XENON;

EID: 2942689616     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeh137     Document Type: Editorial

References (26)

1. Cullen SC, Gross EG. The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 1951; 113: 580-3
2. Sanders RD, Franks NP, Maze M. Xenon: no stranger to anaesthesia. Br J Anaesth 2003; 91: 709-17
3. Franks NP, Dickinson R, De Sousa SL, Hall AC, Lieb WR. How does xenon produce anaesthesia? Nature 1998; 396: 324
4. Luttropp HH, Romner B, Perhag L, Eskilsson J, Fredriksen S, Werner O. Left ventricular performance and cerebral haemodynamics during xenon anaesthesia. A transoesophageal echocardiography and transcranial Doppler sonography study. Anaesthesia 1993; 48: 1045-9
5. Nakata Y, Goto T, Morita S. Effects of xenon on hemodynamic responses to skin incision in humans. Anesthesiology 1999; 90: 406-10
6. Dingley J, King R, Hughes L, et al. Exploration of xenon as a potential cardiostable sedative: a comparison with propofol after cardiac surgery. Anaesthesia 2001; 56: 829-35
7. Rossaint R, Reyle-Hahn M, Schulte am Esch J, et al. Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003; 98: 6-13
8. Nakayama H, Takahashi H, Okubo N, Miyabe M, Toyooka H. Xenon and nitrous oxide do not depress cardiac function in an isolated rat heart model. Can J Anesth 2002; 49: 375-9
9. Stowe DF, Rehmert GC, Kwok WM, Weigt HU, Georgieff M, Bosnjak ZJ. Xenon does not alter cardiac function or major cation currents in isolated guinea pig hearts or myocytes. Anesthesiology 2000; 92: 516-22
10. Hüneke R, Jüngling E, Skasa M, Rossaint R, Lückhoff A. Effects of the anesthetic gases xenon, halothane, and isoflurane on calcium and potassium currents in human atrial cardiomyocytes. Anesthesiology 2001; 95: 999-1006
11. Schroth S, Schotten U, Alkanoglu O, Reyle-Hahn M, Hanrath P, Rossaint R. Xenon does not impair the responsiveness of cardiac muscle bundles to positive inotropic and chronotropic stimulation. Anesthesiology 2002; 96: 422-7
12. Marx T, Wagner D, Bäder S, Görtz A, Georgieff M, Fröba G. Hemodynamics and catecholamines in anesthesia with different concentrations of xenon. ACP 1998; 7: 215-21
13. Picker O, Schindler AW, Schwarte LA, et al. Xenon increases total body oxygen consumption during isoflurane anaesthesia in dogs. Br J Anaesth 2002; 88: 546-54
14. Preckel B, Ebel D, Müllenheim J, Frässdorf J, Thämer V, Schlack W. The direct myocardial effects of xenon in the dog heart in vivo. Anesth Analg 2002; 94: 545-51
15. Hettrick DA, Pagel PS, Kersten JR, et al. Cardiovascular effects of xenon in isoflurane-anesthetized dogs with dilated cardiomyopathy. Anesthesiology 1998; 89: 1166-73
16. Preckel B, Schlack W, Heibel T, Rütten H. Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function. Br J Anaesth 2002; 88: 264-9
17. Preckel B, Müllenheim J, Moloschavij A, Thämer V, Schlack W. Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 2000; 91: 1327-32
18. Toma O, Weber NC, Obal D, Preckel B, Schlack W. Xenon induces myocardial protection by preconditioning. Involvement of protein kinase C (PKC). ASA Abstracts 2003; A1540
19. Hofland J, Gültuna I, Tenbrinck R. Xenon anaesthesia for laparoscopic cholecystectomy in a patient with Eisenmenger's syndrome. Br J Anaesth 2001; 86: 882-6
20. Ma D, Yang H, Lynch J, Franks NP, Maze M, Grocott HP. Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 2003; 98: 690-8
21. Schirmer U, Reinelt H, Erber M, Schmidt M, Marx T. Xenon washout during in-vitro extracorporeal circulation using different oxygenators. J Clin Monit Comput 2002; 17: 211-5
22. Schmidt M, Marx T, Kotzerke J, et al. Cerebral and regional organ perfusion in pigs during xenon anaesthesia. Anaesthesia 2001; 56: 1154-9
23. Frietsch T, Bogdanski R, Blobner M, Werner C, Kuschinsky W, Waschke KF. Effects of xenon on cerebral blood flow and cerebral glucose utilization in rats. Anesthesiology 2001; 94: 290-7
24. Fink H, Blobner M, Bogdanski R, Hänel F, Werner C, Kochs E. Effects of xenon on cerebral blood flow and autoregulation: an experimental study in pigs. Br J Anaesth 2000; 84: 221-5
25. Fukuda T, Nakayama H, Yanagi K, et al. The effects of 30% and 60% xenon inhalation on pial vessel diameter and intracranial pressure in rabbits. Anesth Analg 2001; 92: 1245-50
26. Plougmann J, Astrup J, Pedersen J, Gyldensted C. Effect of stable xenon inhalation on intracranial pressure during measurement of cerebral blood flow in head injury. J Neurosurg 1994; 81: 822-8